Legend Biotech shares are trading higher after HC Wainwright raised its price target on the stock from $77 to $82.
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright raised its price target on Legend Biotech (LEGN) shares from $77 to $82, causing the stock to trade higher.
June 06, 2023 | 1:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Legend Biotech's stock is trading higher after HC Wainwright raised its price target from $77 to $82.
The increase in price target by HC Wainwright, a well-known financial firm, indicates a positive outlook for Legend Biotech. This news is likely to boost investor confidence and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100